Bacterial Etiology and Antimicrobial Resistance Pattern of Pediatric Bloodstream Infections in Beijing, 2015–2019

References

• Menon K, Schlapbach LJ, Akech S, et al. Criteria for pediatric sepsis-a systematic review and meta-analysis by the pediatric sepsis definition taskforce. Crit Care Med. 2022;50(1):21–36. doi:10.1097/CCM.0000000000005294
   PubMed Web of Science ®Google Scholar
• Ikuta KS, Swetschinski LR, Robles Aguilar G; Collaborators GAR. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221–2248. doi:10.1016/S0140-6736(22)02185-7
   PubMed Web of Science ®Google Scholar
• Li X, Ye H. Clinical and mortality risk factors in bloodstream infections with carbapenem-resistant Enterobacteriaceae. Can J Infect Dis Med Microbiol. 2017;2017:6212910. doi:10.1155/2017/6212910
   PubMed Web of Science ®Google Scholar
• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
   PubMed Web of Science ®Google Scholar
• Guzek A, Rybicki Z, Wozniak-Kosek A, Tomaszewski D. Bloodstream infections in the intensive care unit: a single-center retrospective bacteriological analysis between 2007 and 2019. Pol J Microbiol. 2022;71(2):263–277. doi:10.33073/pjm-2022-025
   PubMed Web of Science ®Google Scholar
• Kern WV, Rieg S. Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin Microbiol Infect. 2020;26(2):151–157. doi:10.1016/j.cmi.2019.10.031
   PubMed Web of Science ®Google Scholar
• Tsuzuki S, Matsunaga N, Yahara K, Shibayama K, Sugai M, Ohmagari N. Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: a population-level study, Japan, 2015–2018. Int J Infect Dis. 2021;108:119–124. doi:10.1016/j.ijid.2021.05.018
   PubMed Web of Science ®Google Scholar
• Tian L, Sun Z, Zhang Z. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. BMC Public Health. 2018;18(1):1121. doi:10.1186/s12889-018-6013-5
   PubMed Web of Science ®Google Scholar
• Wang S, Chen S, Feng W, et al. Clinical characteristics of nosocomial bloodstream infections in neonates in two hospitals, China. J Trop Pediatr. 2018;64(3):231–236. doi:10.1093/tropej/fmx054
   PubMed Web of Science ®Google Scholar
• Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857–2876. doi:10.1080/10408398.2015.1077192
   PubMed Web of Science ®Google Scholar
• Ikhimiukor OO, Odih EE, Donado-Godoy P, Okeke IN. A bottom-up view of antimicrobial resistance transmission in developing countries. Nat Microbiol. 2022;7(6):757–765. doi:10.1038/s41564-022-01124-w
   PubMed Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–S134. doi:10.1093/cid/ciy657
   PubMed Web of Science ®Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing. 29th ed. In: CLSI Supplement M100. Wayne (USA): Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• Cui J, Li M, Cui J, Wang J, Qiang X, Liang Z. The proportion, species distribution and dynamic trends of bloodstream infection cases in a tertiary hospital in China, 2010–2019. Infection. 2022;50(1):121–130. doi:10.1007/s15010-021-01649-y
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Tao Y, Ding Y, Shao X, Li W. Epidemiology and drug resistance of neonatal bloodstream infection pathogens in East China children’s Medical Center from 2016 to 2020. Front Microbiol. 2022;13:820577. doi:10.3389/fmicb.2022.820577
   PubMed Web of Science ®Google Scholar
• Widmer AF, Lakatos B, Frei R. Strict infection control leads to low incidence of methicillin-resistant Staphylococcus aureus bloodstream infection over 20 years. Infect Control Hosp Epidemiol. 2015;36(6):702–709. doi:10.1017/ice.2015.28
   PubMed Web of Science ®Google Scholar
• Larru B, Gong W, Vendetti N, et al. Bloodstream infections in hospitalized children: epidemiology and antimicrobial susceptibilities. Pediatr Infect Dis J. 2016;35(5):507–510. doi:10.1097/INF.0000000000001057
   PubMed Web of Science ®Google Scholar
• Huttunen R, Attman E, Aittoniemi J, et al. Nosocomial bloodstream infections in a Finnish tertiary care hospital: a retrospective cohort study of 2175 episodes during the years 1999–2001 and 2005–2010. Infect Dis (Lond). 2015;47(1):20–26. doi:10.3109/00365548.2014.956791
   PubMed Web of Science ®Google Scholar
• Qiu Y, Yang J, Chen Y, et al. Microbiological profiles and antimicrobial resistance patterns of pediatric bloodstream pathogens in China, 2016–2018. Eur J Clin Microbiol Infect Dis. 2021;40(4):739–749. doi:10.1007/s10096-020-04069-2
   PubMed Web of Science ®Google Scholar
• Bielicki JA, Lundin R, Sharland M. Antibiotic resistance prevalence in routine bloodstream isolates from children’s hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J. 2015;34(7):734–741. doi:10.1097/INF.0000000000000652
   PubMed Web of Science ®Google Scholar
• Musicha P, Cornick JE, Bar-Zeev N, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042–1052. doi:10.1016/S1473-3099(17)30394-8
   PubMed Web of Science ®Google Scholar
• He S, Lin J, Li Y, et al. Insights into the epidemiology of methicillin-resistant coagulase-negative Staphylococci carriage in community-based drug users. J Infect Public Health. 2020;13(11):1742–1748. doi:10.1016/j.jiph.2020.09.011
   PubMed Web of Science ®Google Scholar
• Monaco M, Pimentel de Araujo F, Cruciani M, Coccia EM, Pantosti A. Worldwide epidemiology and antibiotic resistance of Staphylococcus aureus. Curr Top Microbiol Immunol. 2017;409:21–56. doi:10.1007/82_2016_3
   PubMed Web of Science ®Google Scholar
• Buetti N, Atkinson A, Kottanattu L, Bielicki J, Marschall J, Kronenberg A. Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study. Eur J Clin Microbiol Infect Dis. 2017;36(3):537–544. doi:10.1007/s10096-016-2830-6
   PubMed Web of Science ®Google Scholar
• Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010. JAMA. 2012;308(1):50–59. doi:10.1001/jama.2012.7139
   PubMed Web of Science ®Google Scholar
• Zhao C, Li Z, Zhang F, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis. 2017;17(1):804. doi:10.1186/s12879-017-2880-0
   PubMedGoogle Scholar
• Mun SJ, Kim SH, Kim HT, Moon C, Wi YM. The epidemiology of bloodstream infection contributing to mortality: the difference between community-acquired, healthcare-associated, and hospital-acquired infections. BMC Infect Dis. 2022;22(1):336. doi:10.1186/s12879-022-07267-9
   PubMed Web of Science ®Google Scholar
• Stewardson A, Fankhauser C, De Angelis G, et al. Burden of bloodstream infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol. 2013;34(2):133–143. doi:10.1086/669086
   PubMed Web of Science ®Google Scholar
• Somily AM, Habib HA, Absar MM, et al. ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia. J Infect Dev Ctries. 2014;8(9):1129–1136. doi:10.3855/jidc.4292
   PubMed Web of Science ®Google Scholar
• Liu J, Du SX, Zhang JN, Liu SH, Zhou YY, Wang XR. Spreading of extended-spectrum beta-lactamase-producing Escherichia coli ST131 and Klebsiella pneumoniae ST11 in patients with pneumonia: a molecular epidemiological study. Chin Med J (Engl). 2019;132(16):1894–1902. doi:10.1097/CM9.0000000000000368
   PubMed Web of Science ®Google Scholar
• System CARS. 2014至2017年中国儿童及新生儿患者细菌耐药监测研究 [Surveillance of bacterial resistance in children and newborns across China from 2014 to 2017]. Zhonghua Yi Xue Za Zhi. 2018;98(40):3279–3287. Chinese. doi:10.3760/cma.j.issn.0376-2491.2018.40.013
   PubMedGoogle Scholar
• De Laveleye M, Huang TD, Bogaerts P, et al. Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals. Eur J Clin Microbiol Infect Dis. 2017;36(1):139–146. doi:10.1007/s10096-016-2782-x
   PubMed Web of Science ®Google Scholar
• Moghnieh R, Abdallah D, Jadayel M, et al. Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales. Sci Rep. 2021;11(1):14757. doi:10.1038/s41598-021-94295-1
   PubMed Web of Science ®Google Scholar
• Horikoshi Y, Suwa J, Higuchi H, et al. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis. 2017;64:69–73. doi:10.1016/j.ijid.2017.09.012
   PubMed Web of Science ®Google Scholar
• Probst V, Islamovic F, Mirza A. Antimicrobial stewardship program in pediatric medicine. Pediatr Investig. 2021;5(3):229–238. doi:10.1002/ped4.12292
   PubMedGoogle Scholar
• Leistner R, Gurntke S, Sakellariou C, et al. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort. Infection. 2014;42(6):991–997. doi:10.1007/s15010-014-0670-9
   PubMed Web of Science ®Google Scholar
• Timsit JF, Ruppe E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46(2):266–284. doi:10.1007/s00134-020-05950-6
   PubMed Web of Science ®Google Scholar
• Dugar S, Choudhary C, Duggal A. Sepsis and septic shock: guideline-based management. Cleve Clin J Med. 2020;87(1):53–64. doi:10.3949/ccjm.87a.18143
   PubMed Web of Science ®Google Scholar
• Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755. doi:10.1097/CCM.0000000000000330
   PubMed Web of Science ®Google Scholar